These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25577892)

  • 1. Stability and in vitro toxicity of an infliximab eye drop formulation.
    Robert MC; Spurr-Michaud S; Frenette M; Young D; Gipson IK; Dohlman CH
    Int J Pharm Compd; 2014; 18(5):418-26. PubMed ID: 25577892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab stability after reconstitution, dilution, and storage under refrigeration.
    Beer PM; Wong SJ; Schartman JP; Kulas KE; Hartman CL; Giganti M; Falk NS
    Retina; 2010 Jan; 30(1):81-4. PubMed ID: 20010324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of topical infliximab in a mouse model of experimental dry eye.
    Li Z; Choi W; Oh HJ; Yoon KC
    Cornea; 2012 Nov; 31 Suppl 1():S25-31. PubMed ID: 23038030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological Stability of Plasma Rich in Growth Factors Eye Drops After Storage of 3 Months.
    Anitua E; Muruzabal F; Pino A; Merayo-Lloves J; Orive G
    Cornea; 2013 Oct; 32(10):1380-6. PubMed ID: 23974892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA).
    Hermosilla J; Sánchez-Martín R; Pérez-Robles R; Salmerón-García A; Casares S; Cabeza J; Cuadros-Rodríguez L; Navas N
    BioDrugs; 2019 Apr; 33(2):193-205. PubMed ID: 30875076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop.
    Anitua E; Muruzabal F; De la Fuente M; Merayo-Lloves J; Orive G
    Exp Eye Res; 2014 Feb; 119():27-34. PubMed ID: 24345372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring.
    Ferrari G; Bignami F; Giacomini C; Franchini S; Rama P
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1680-8. PubMed ID: 23404121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of serum eye drops after storage of 6 months.
    Fischer KR; Opitz A; Böeck M; Geerling G
    Cornea; 2012 Nov; 31(11):1313-8. PubMed ID: 22955119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of Biological Activity of Plasma and Platelet-Derived Eye Drops After Their Different Time and Temperature Conditions of Storage.
    Anitua E; de la Fuente M; Riestra A; Merayo-Lloves J; Muruzábal F; Orive G
    Cornea; 2015 Sep; 34(9):1144-8. PubMed ID: 26165790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical and microbiological stability study of two new preservative-free methylprednisolone eye drops.
    Merino-Bohórquez V; Berisa-Prado S; Delgado-Valverde M; Tirado-Pérez MJ; García-Palomo M; Alonso-Herreros JM; Cañete-Ramírez C; Dávila-Pousa MD;
    Farm Hosp; 2024; 48(4):145-152. PubMed ID: 38570209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of vancomycin in an extemporaneously compounded ophthalmic solution.
    Fuhrman LC; Stroman RT
    Am J Health Syst Pharm; 1998 Jul; 55(13):1386-8. PubMed ID: 9659967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Translated article] Physicochemical and microbiological stability study of two new preservative-free methylprednisolone eye drops.
    Merino-Bohórquez V; Berisa-Prado S; Delgado-Valverde M; Tirado-Pérez MJ; García-Palomo M; Alonso-Herreros JM; Cañete-Ramírez C; Dávila-Pousa MD
    Farm Hosp; 2024; 48(4):T145-T152. PubMed ID: 38782645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of an extemporaneously prepared recombinant human interferon alfa-2b eye drop formulation.
    Ruiz L; Rodriguez I; Baez R; Aldana R
    Am J Health Syst Pharm; 2007 Aug; 64(16):1716-9. PubMed ID: 17687060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
    Kodym A; Wiśniewski A; Knioła D; Olejniczak M
    Acta Pol Pharm; 2011; 68(4):555-64. PubMed ID: 21796938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops.
    Fernández-Ferreiro A; Santiago-Varela M; Gil-Martínez M; González-Barcia M; Luaces-Rodríguez A; Díaz-Tome V; Pardo M; Méndez JB; Piñeiro-Ces A; Rodríguez-Ares MT; Lamas MJ; Otero-Espinar FJ
    J Ocul Pharmacol Ther; 2017 Apr; 33(3):202-209. PubMed ID: 28384032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing cefazolin.
    Kodym A; Zawisza T; Buźka K; Kukuła H
    Acta Pol Pharm; 2006; 63(3):225-34. PubMed ID: 20085229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of ceftazidime in a viscous eye drop formulation.
    Barnes AR; Nash S
    J Clin Pharm Ther; 1999 Aug; 24(4):299-302. PubMed ID: 10475988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW; Kao A; Williams T; Lambert RW
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding.
    Chen P; Mar Z; Giannetti A; Hughes S; Gilbert J; Zhao F
    Hosp Pharm; 2022 Feb; 57(1):69-75. PubMed ID: 35521008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.